We surveyed 7,000 people in seven countries to find out what they know about multiple sclerosis (MS). Our survey identified several surprising misconceptions.

Learn about how digital is changing the face of patient advocacy.

Novartis is working to tackle the problem of counterfeit drugs, which are a threat to patient health.

A Novartis experimental drug in clinical trial aims to block liver cancer growth

The Novartis Faculty of Scholars initiative connects academic researchers with deep knowledge and big ideas to scientists in its drug discovery labs.

Kristen Harrington-Smith discusses her work as Vice President and Head of CAR-T US at Novartis Oncology.

Researchers race to put hydroxychloroquine to the test in a large study.

Explaining Chagas disease through the stories of patients in Latin America.

Chronic diseases like cancer and diabetes were once the preserve of wealthy countries but are now increasingly common in lower-income countries too as populations age and lifestyles change.